Church & Dwight vs Colgate-Palmolive
Add, change or remove companies; up to four.
The short version
- Colgate-Palmolive is the larger business, with $20.4B of revenue in fiscal 2025 against $6.2B for Church & Dwight, about 3.3 times as much.
- Church & Dwight kept more of each dollar of sales as operating profit (17.4% operating margin, against 16.2%).
- Colgate-Palmolive earned a higher return on the capital invested in it (37.3%, against 14.6%).
- Investors pay more for each dollar of Colgate-Palmolive’s earnings: a P/E of 37.2x against 33.7x for Church & Dwight.
| Latest fiscal year | CHD · FY25 | CL · FY25 |
|---|---|---|
| Size | ||
| Market cap | $25.1B | $75.4B |
| Revenue | $6.2B | $20.4B |
| Free cash flow | $1.1B | $3.6B |
| Net income | $737M | $2.1B |
| Growth | ||
| Revenue growth | 1.6% | 1.4% |
| 5-year growth | 4.9% | 4.4% |
| Share count change | −1.1% | −1.5% |
| Profitability | ||
| Gross margin | 44.7% | 60.1% |
| Operating margin | 17.4% | 16.2% |
| Net margin | 11.9% | 10.5% |
| FCF margin | 17.6% | 17.8% |
| Return on capital | 14.6% | 37.3% |
| Return on equity | 17.6% | — |
| Balance sheet | ||
| Net debt | $1.8B | $6.4B |
| Net debt / EBITDA | 1.4x | 1.6x |
| Dividends and buybacks | $1.2B | $3.0B |
| Valuation & quality | ||
| P/E | 33.7x | 37.2x |
| Piotroski F-score | 6 | 5 |
FY16
CHD $3.5B
CL $15.2B
FY17
CHD $3.8B
CL $15.5B
FY18
CHD $4.1B
CL $15.5B
FY19
CHD $4.4B
CL $15.7B
FY20
CHD $4.9B
CL $16.5B
FY21
CHD $5.2B
CL $17.4B
FY22
CHD $5.4B
CL $18.0B
FY23
CHD $5.9B
CL $19.5B
FY24
CHD $6.1B
CL $20.1B
FY25
CHD $6.2B
CL $20.4B
CHD
CL
FY16
CHD 20.7%
CL 26.0%
FY17
CHD 19.4%
CL 24.0%
FY18
CHD 19.1%
CL 23.8%
FY19
CHD 19.3%
CL 22.7%
FY20
CHD 21.0%
CL 23.6%
FY21
CHD 20.8%
CL 19.1%
FY22
CHD 11.1%
CL 16.1%
FY23
CHD 18.0%
CL 20.5%
FY24
CHD 13.2%
CL 21.2%
FY25
CHD 17.4%
CL 16.2%
CHD
CL
FY16
CHD $606M
CL $2.5B
FY17
CHD $637M
CL $2.5B
FY18
CHD $703M
CL $2.6B
FY19
CHD $791M
CL $2.8B
FY20
CHD $891M
CL $3.3B
FY21
CHD $875M
CL $2.8B
FY22
CHD $706M
CL $1.9B
FY23
CHD $807M
CL $3.0B
FY24
CHD $976M
CL $3.5B
FY25
CHD $1.1B
CL $3.6B
CHD
CL
FY16
CHD 16.7%
CL 50.9%
FY17
CHD 20.3%
CL 44.0%
FY18
CHD 14.6%
CL 49.2%
FY19
CHD 15.2%
CL 41.6%
FY20
CHD 17.4%
CL 41.1%
FY21
CHD 16.4%
CL 33.9%
FY22
CHD 8.3%
CL 26.5%
FY23
CHD 14.0%
CL 34.3%
FY24
CHD 10.9%
CL 45.9%
FY25
CHD 14.6%
CL 37.3%
CHD
CL
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.